Top Markets
Coin of the day
I'rom Group Co., Ltd. I'rom Group Co., Ltd.

I'rom Group Co., Ltd.

2372
주식 순위 #17926
I'rom Group Co., Ltd. is a Japanese enterprise specializing in several key... I'rom Group Co., Ltd. is a Japanese enterprise specializing in several key areas: pioneering advanced medical treatments, offering site management organization (SMO) services, acting as a contract research organization (CRO), and providing various forms of medical support. The company spearheads the creation of cutting-edge medical technologies, particularly in regenerative medicine and gene therapy, to combat conditions like obstructive arteriosclerosis, retinitis pigmentosa, and HIV/AIDS. Their innovative contributions include the Sendai virus vector and the CytoTune-iPS kit, designed for generating induced pluripotent stem cells. Furthermore, I'rom assists medical institutions with clinical trial execution and delivers extensive support for the development of novel drugs and medical equipment, with a focus on cancer, rare, and intractable diseases. The company also oversees the establishment and operation of clinic malls. Founded in Tokyo in 1997, it was formerly known as I'Rom Holdings Co., Ltd. until its name change in July 2015.
주가
$18.20
마지막 동기화: 2025-05-09
시가총액
$220.35M
변동 (1일)
-5.34%
변동 (1년)
0.00%
국가
JP
거래 I'rom Group Co., Ltd. (2372)

카테고리

I'rom Group Co., Ltd. (2372)의 EPS
December 2024 기준 EPS TTM: $0.43
I'rom Group Co., Ltd.의 최신 재무 보고서와 주가에 따르면, 현재 EPS (TTM)는 $0.43입니다. 2023년 말에는 회사의 EPS가 $1.58였으며, 이는 2022년의 EPS $1.33와 증가입니다.
I'rom Group Co., Ltd.의 EPS 기록 (2005 ~ 2026)
매년 말의 EPS
연도 EPS 변화
2026 (TTM) $0.43 -44.79%
2024 $0.77 -51.22%
2023 $1.58 18.66%
2022 $1.33 29.35%
2021 $1.03 4.82%
2020 $0.98 39.61%
2019 $0.70 -44.65%
2018 $1.27 655.85%
2017 $0.17 -123.18%
2016 $-0.73 47.56%
2015 $-0.49 65.25%
2014 $-0.30 -115.00%
2013 $1.99 -523.60%
2012 $-0.47 -260.82%
2011 $0.29 -134.87%
2010 $-0.84 -92.71%
2009 $-11.47 881.67%
2008 $-1.17 91.37%
2007 $-0.61 -246.33%
2006 $0.42 -56.53%
2005 $0.96 0.00%
유사 기업 또는 경쟁사의 EPS